Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EverCommerce (EVCM) Liabilities and Shareholders Equity (2020 - 2025)

EverCommerce (EVCM) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $1.4 billion in Q2 2025.

  • For Q2 2025, Liabilities and Shareholders Equity fell 3.28% year-over-year to $1.4 billion; the TTM value through Sep 2025 reached $4.3 billion, down 28.12%, while the annual FY2024 figure was $1.4 billion, 6.38% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.4 billion in Q2 2025 per EVCM's latest filing, roughly flat from $1.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.7 billion in Q4 2021 and bottomed at $1.4 billion in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 25.29% in 2021, then dropped 6.38% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 billion in 2021, then fell by 4.31% to $1.6 billion in 2022, then decreased by 4.63% to $1.5 billion in 2023, then dropped by 6.38% to $1.4 billion in 2024, then decreased by 0.16% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $1.4 billion in Q2 2025, $1.4 billion in Q1 2025, and $1.4 billion in Q4 2024.